Neogen Corporation (NASDAQ:NEOG)
9.31 USD
+0.380 4.255%Sponsored Reports
| Previous Close (in USD) | 8.93 |
|---|---|
| Change | +0.380 4.255% |
| 52 W H/L (in USD) | 24.095/11.460 |
| EBITDA (in USD) | 246.76M |
| PE Ratio | 676.00 |
| Volume | 5065588 |
| Diluted Eps TTM | 0.02 |
| Total Assets (in USD) | 4554.432M |
|---|---|
| Total Liabilities (in USD) | 1420.215M |
| Revenue TTM (in USD) | 929.238M |
| Cash (in USD) | 163.24M |
| Market Cap (in USD) | 2,928.540 M |
| Revenue Per Share TTM | 4.293 |
| Gross Profit TTM (in USD) | 409.2M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Neogen Corporation
Employees: 2640
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. John Edward Adent | Pres, CEO & Director | 1968 |
| 2. | Mr. Steven J. Quinlan | VP & CFO | 1962 |
| 3. | Mr. Douglas E. Jones | COO & VP | 1970 |
| 4. | Sarah Demey | Admin. Mang. | NA |
| 5. | Ms. Amy M. Rocklin Ph.D. | VP, Gen. Counsel & Corp. Sec. | 1972 |
| 6. | Ms. Julie A. Mann | VP & Chief HR Officer | 1965 |
| 7. | Mr. John Edward Adent | President, CEO & Director | 1968 |
| 8. | Mr. David H. Naemura | Chief Financial Officer | 1970 |
| 9. | Dr. Robert S. Donofrio Ph.D. | VP & Chief Scientific Officer | 1975 |
| 10. | Sarah Demey | Administrative Manager | NA |
Peers
Sector: Healthcare
Industry: Diagnostics & Research
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
TMO
Thermo Fisher Scientific Inc |
+2.920 0.633% | 461.63 | 34.710 | 23.866 | 4.622 | 4.428 | 5.293 | 20.886 |
|
DHR
Danaher Corporation |
-0.590 0.332% | 175.55 | 29.090 | 28.011 | 5.669 | 3.198 | 5.999 | 19.094 |
|
A
Agilent Technologies Inc |
+2.730 2.196% | 125.56 | 34.360 | 26.385 | 6.587 | 7.136 | 6.781 | 23.557 |
|
IDXX
IDEXX Laboratories Inc |
+16.000 2.930% | 549.29 | 49.990 | 45.662 | 11.293 | 27.850 | 11.461 | 34.457 |
Income Statement
(Currency in USD)| Breakdown | 31-05-2023 | 31-05-2022 | 31-05-2021 | 31-05-2020 | 31-05-2019 |
|---|---|---|---|---|---|
| Income Before Tax | -22.042M | 60.207M | 75.268M | 72.305M | 72.959M |
| Minority Interest | - | - | - | 0M | 0M |
| Net Income | -22.87M | 48.307M | 60.882M | 59.475M | 60.176M |
| Selling General Administrative | 201.179M | 82.742M | 51.197M | 44.331M | 40.791M |
| Gross Profit | 405.955M | 243.013M | 215.056M | 196.279M | 191.92M |
| Reconciled Depreciation | 88.377M | 23.694M | 21.041M | 18.396M | 17.624M |
| Ebit | -50.862M | 34.924M | 53.128M | 49.127M | 50.47M |
| Ebitda | 37.515M | 58.618M | 74.169M | 67.523M | 68.094M |
| Depreciation And Amortization | 88.377M | 23.694M | 21.041M | 18.396M | 17.624M |
| Operating Income | 37.515M | 34.924M | 53.128M | 49.127M | 50.47M |
| Other Operating Expenses | 784.932M | 468.541M | 394.29M | 350.647M | 346.092M |
| Interest Expense | 55.961M | 1.267M | 22.14M | 23.178M | 22.489M |
| Tax Provision | 0.828M | 11.9M | 14.386M | 12.83M | 12.783M |
| Interest Income | 3.166M | 1.267M | 1.614M | 5.992M | 4.683M |
| Net Interest Income | -52.795M | 1.267M | 1.614M | 5.992M | 4.683M |
| Income Tax Expense | 0.828M | 11.9M | 14.386M | 12.83M | 12.783M |
| Total Revenue | 822.447M | 527.159M | 468.459M | 418.17M | 414.186M |
| Total Operating Expenses | 368.44M | 184.395M | 140.887M | 128.756M | 123.826M |
| Cost Of Revenue | 416.492M | 284.146M | 253.403M | 221.891M | 222.266M |
| Total Other Income Expense Net | -59.557M | 25.283M | 22.14M | 23.178M | 22.489M |
| Net Income From Continuing Ops | -22.87M | 48.307M | 60.882M | 59.475M | 60.176M |
| Net Income Applicable To Common Shares | -22.87M | 48.307M | 60.882M | 59.475M | 60.176M |
Balance Sheet
(Currency in USD)| Breakdown | 31-05-2023 | 31-05-2022 | 31-05-2021 | 31-05-2020 | 31-05-2019 |
|---|---|---|---|---|---|
| Total Assets | 4554.432M | 992.929M | 920.192M | 797.182M | 695.74M |
| Intangible Assets | 1605.102M | 107.503M | 92.316M | 66.581M | 67.745M |
| Other Current Assets | 53.297M | 23.76M | 17.84M | 13.999M | 13.431M |
| Total Liab | 1420.215M | 105.555M | 79.815M | 72.005M | 57.841M |
| Total Stockholder Equity | 3134.217M | 887.374M | 840.377M | 725.177M | 637.899M |
| Other Current Liab | 64.187M | 37.77M | 29.699M | 22.839M | 19.188M |
| Common Stock | 34.599M | 17.248M | 17.195M | 8.471M | 8.355M |
| Capital Stock | 34.599M | 17.248M | 17.195M | 8.471M | 8.355M |
| Retained Earnings | 565.041M | 587.911M | 539.604M | 478.722M | 419.247M |
| Good Will | 3769.752M | 255.547M | 228.288M | 181.105M | 171.364M |
| Other Assets | 15.22M | 4799.026M | 2.019M | 2.232M | 0.139M |
| Cash | 163.24M | 381.051M | 381.087M | 343.673M | 267.524M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 145.472M | 77.844M | 53.599M | 48.489M | 38.251M |
| Current Deferred Revenue | 4.616M | 5.46M | - | - | - |
| Net Debt | 736.76M | 605.637M | -381.087M | -343.673M | -267.524M |
| Short Term Debt | - | - | - | - | - |
| Short Long Term Debt | - | - | - | - | - |
| Short Long Term Debt Total | 900M | 986.688M | - | - | - |
| Other Stockholder Equity | 2567.828M | 309.984M | 294.953M | 257.693M | 221.937M |
| Property Plant Equipment | 198.749M | 110.584M | 100.453M | 78.671M | 74.847M |
| Total Current Assets | 585.931M | 626.798M | 591.451M | 537.406M | 449.529M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | 82.329M | 336.578M | 305.485M | 277.404M | 225.836M |
| Net Receivables | 153.253M | 99.674M | 91.823M | 84.681M | 82.582M |
| Long Term Debt | 885.439M | - | - | - | - |
| Inventory | 133.812M | 122.313M | 100.701M | 95.053M | 85.992M |
| Accounts Payable | 76.669M | 34.614M | 23.9M | 25.65M | 19.063M |
| Accumulated Other Comprehensive Income | -33.251M | -27.769M | -11.375M | -19.709M | -11.64M |
| Non Currrent Assets Other | 3769.752M | 2.156M | 2.019M | 2.232M | -15.618M |
| Non Current Assets Total | 3968.501M | 366.131M | 328.741M | 259.776M | 246.211M |
| Capital Lease Obligations | - | - | - | - | - |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-05-2023 | 31-05-2022 | 31-05-2021 | 31-05-2020 | 31-05-2019 |
|---|---|---|---|---|---|
| Investments | 254.249M | -34.055M | -28.081M | -51.569M | -98.099M |
| Total Cashflows From Investing Activities | 201.039M | -97.229M | -105.564M | -88.785M | -119.148M |
| Total Cash From Financing Activities | -118.081M | 6.813M | 33.544M | 29.405M | 13.899M |
| Net Income | -22.87M | 48.307M | 60.882M | 59.475M | 60.176M |
| Change In Cash | 118.767M | -31.129M | 9.333M | 24.581M | -41.386M |
| Begin Period Cash Flow | 44.473M | 75.602M | 66.269M | 41.688M | 83.074M |
| End Period Cash Flow | 163.24M | 44.473M | 75.602M | 66.269M | 41.688M |
| Total Cash From Operating Activities | 41.028M | 68.038M | 81.089M | 85.878M | 63.842M |
| Depreciation | 88.377M | 23.694M | 21.041M | 18.396M | 17.624M |
| Other Cashflows From Investing Activities | 12.547M | -38.745M | -50.771M | -13.164M | -6.388M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | 9.955M | -21.072M | 2.45M | -10.011M | -10.437M |
| Sale Purchase Of Stock | 1.195M | 7.933M | 34.631M | 29.405M | -3.135M |
| Other Cashflows From Financing Activities | -19.276M | -1.12M | -1.087M | 29.405M | 13.899M |
| Capital Expenditures | 65.757M | 24.429M | 26.712M | 24.052M | 14.661M |
| Change In Working Capital | -22.785M | -6.422M | -6.631M | -0.062M | -20.698M |
| Other Non Cash Items | 7.359M | 73.197M | 51.87M | 49.407M | 56.714M |
| Free Cash Flow | -24.729M | 43.609M | 54.377M | 61.826M | 49.181M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | iShares Core S&P Mid-Cap ETF | 2 years ago | 6112196 |
| 2. | Vanguard Total Stock Mkt Idx Inv | 2 years ago | 5950859 |
| 3. | iShares Russell 2000 ETF | 2 years ago | 5078169 |
| 4. | Baron Small Cap Retail | 2 years ago | 5000000 |
| 5. | Baron Opp. Small Cap Growth Strategy | 2 years ago | 5000000 |
| 6. | Vanguard Small Cap Index | 2 years ago | 4958083 |
| 7. | Canada Life US Small-Mid Cap Growth A | 2 years ago | 4736454 |
| 8. | Conestoga Small Cap Investors | 2 years ago | 4282291 |
| 9. | Champlain Small Company Fund, LLC | 2 years ago | 4186096 |
| 10. | Calvert Small-Cap A | 2 years ago | 3260543 |
| 11. | Calvert US Small-Cap Strategy | 2 years ago | 3260543 |
| 12. | Vanguard Institutional Extnd Mkt Idx Tr | 2 years ago | 2947997 |
| 13. | Vanguard Small Cap Growth Index Inv | 2 years ago | 2800626 |
| 14. | Janus Henderson Triton D | 2 years ago | 2306461 |
| 15. | Janus Henderson US SMID Cap Growth | 2 years ago | 2306461 |
| 16. | Champlain Small Company Adv | 2 years ago | 2300000 |
| 17. | T. Rowe Price US Small-Cap Core Equity | 2 years ago | 2246744 |
| 18. | T. Rowe Price Small-Cap Stock | 2 years ago | 2246744 |
| 19. | Fidelity Small Cap Index | 2 years ago | 2223012 |
| 20. | JPMorgan Small Cap Equity A | 2 years ago | 2216777 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | BlackRock Inc | 2 years ago | 24852060 |
| 2. | Vanguard Group Inc | 2 years ago | 19715974 |
| 3. | NORGES BANK | 2 years ago | 18189674 |
| 4. | Select Equity Group LP | 2 years ago | 12615546 |
| 5. | Baillie Gifford & Co Limited. | 2 years ago | 11789521 |
| 6. | Mackenzie Investments | 2 years ago | 7489893 |
| 7. | State Street Corporation | 2 years ago | 7460004 |
| 8. | BAMCO Inc | 2 years ago | 7304967 |
| 9. | William Blair Investment Management, LLC | 2 years ago | 7295376 |
| 10. | Conestoga Capital Advisors, LLC | 2 years ago | 6865041 |
| 11. | Morgan Stanley - Brokerage Accounts | 2 years ago | 5923892 |
| 12. | RIVULET CAPITAL, LLC | 2 years ago | 5900000 |
| 13. | T. Rowe Price Investment Management,Inc. | 2 years ago | 5760225 |
| 14. | King Luther Capital Management Corp | 2 years ago | 5697061 |
| 15. | Champlain Investment Partners, LLC | 2 years ago | 5560871 |
| 16. | Geode Capital Management, LLC | 2 years ago | 4699630 |
| 17. | JPMorgan Chase & Co | 2 years ago | 3901887 |
| 18. | Northern Trust Corp | 2 years ago | 3804814 |
| 19. | HHG PLC | 2 years ago | 3628801 |
| 20. | Blair William & Co | 2 years ago | 3220866 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).